|
Безопасность и качество пищевых продуктов
|
|
|
| |
Online help Terminology
This database contains the most recent information on maximum residue levels for veterinary drugs as recommended by JECFA. All monographs published in the FAO Food and Nutrition Papers 41 can be accessed in an electronic format. These monographs are available only in English although some parts of the database, the query page as well as the background information are provided in English, French, Spanish, Arabic and Chinese.
| Veterinary Drug |
Avilamycin |
| Functional class |
Antimicrobial agent |
| Latest evaluation |
2008 |
| JECFA meeting |
70 |
| ADI |
0-2 mg/kg bw |
| ADI status |
Full |
| Residue monographs |
|
| Marker residue |
Dichloroisoeverninic acid (DIA) |
Maximum residue limits (MRL) recommended |
| Chicken | Fat/Skin | 200 µg/kg | F | | Chicken | Kidney | 200 µg/kg | F | | Chicken | Liver | 300 µg/kg | F | | Chicken | Muscle | 200 µg/kg | F | | Pig | Fat/Skin | 200 µg/kg | F | | Pig | Kidney | 200 µg/kg | F | | Pig | Liver | 300 µg/kg | F | | Pig | Muscle | 200 µg/kg | F | | Rabbit | Fat/Skin | 200 µg/kg | F | | Rabbit | Kidney | 200 µg/kg | F | | Rabbit | Liver | 300 µg/kg | F | | Rabbit | Muscle | 200 µg/kg | F | | Turkey | Fat/Skin | 200 µg/kg | F | | Turkey | Kidney | 200 µg/kg | F | | Turkey | Liver | 300 µg/kg | F | | Turkey | Muscle | 200 µg/kg | F |
|
| Other remarks |
|
| Summary of the evaluation |
The ADI of 0-2 mg/kg bodyweight (0-120 mg per day for a 60 kg person) was established on the basis of a NOAEL of 150 mg/kg avilamycin activity/kg bodyweight and day and a safety factor of 100 and rounding to one significant figure. Residue concentrations of the marker residue were not quantifiable or detected in muscle, skin/fat and kidney in pigs and chickens at a withdrawal time of 0 h or greater. Low residue concentrations were present in liver of all species studied in the first hours post-treatment, but were not quantifiable or detected after 24 h withdrawal. The Estimated Daily Intake (EDI) was not determined because of insufficient quantifiable data points with which to calculate the median values of residues (low quantities of residues or absence of quantifiable residues). Using the model diet and the ratio of avilamycin equivalents to DIA, the recommended MRLs would result in a daily intake of 5.3 mg of avilamycin, approximately 4% of the upper bound of the ADI. |
|
|
|